Publications from the Centre for Immuno-Oncology
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution.
Journal article
Puttick C. et al, (2024), Nature genetics
Novel H-2D<sup>b</sup>-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice.
Journal article
McAuliffe J. et al, (2024), Journal for immunotherapy of cancer, 12
High proportion of PD-1 and CD39 positive CD8+ tissue resident T lymphocytes correlates with better clinical outcome in resected human oesophageal adenocarcinoma
Journal article
Hill SL. et al, (2024), Cancer Immunology, Immunotherapy, 73
Association Between Vitamin D Insufficiency and Impaired Bone Density Among Adolescents With Perinatally Acquired HIV Infection.
Journal article
Dzavakwa NV. et al, (2024), Open forum infectious diseases, 11
Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer.
Journal article
Javed SR. et al, (2024), British journal of cancer
MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers.
Journal article
Eguren-Santamaria I. et al, (2024), Journal for immunotherapy of cancer, 12
CD137 (4-1BB) and T-Lymphocyte Exhaustion.
Journal article
Molero-Glez P. et al, (2024), Clin Cancer Res, OF1 - OF3
Regulation of the cell surface expression of classical and non-classical MHC proteins by the human cytomegalovirus UL40 and rhesus cytomegalovirus Rh67 proteins.
Journal article
Brackenridge S. et al, (2024), Journal of virology
Testing new anticancer drugs before curative locoregional therapies: MDICT 2024 recommendations
Journal article
(2024), ESMO Open, 9, 103649 - 103649
Integrating Patient and Public Involvement and Engagement in Translational Medicine
Journal article
Borrow P. et al, (2024), The Lancet
A high affinity monoclonal antibody against HLA-E-VL9 enhances natural killer cell anti-tumor killing
Preprint
Hwang JK. et al, (2024)
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx.
Journal article
Frankell AM. et al, (2024), Nature, 631
Cross-talk between ILC2 and Gata3high Tregs locally constrains adaptive type 2 immunity.
Journal article
Stockis J. et al, (2024), Science immunology, 9
Identification and structural characterization of a mutant KRAS-G12V specific TCR restricted by HLA-A3.
Journal article
Sim MJW. et al, (2024), European journal of immunology
Mucosal signatures of pathogenic T cells in HLA-B*27+ anterior uveitis and axial spondyloarthritis.
Journal article
Paley MA. et al, (2024), JCI insight
Update: Vitamin D3 and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trial.
Journal article
Dzavakwa NV. et al, (2024), Trials, 25
Closing the equity gap in the treatment of HIV-2 infection.
Journal article
Rowland-Jones S. and Gea-Mallorquí E., (2024), The lancet. HIV, 11, e347 - e349
Double-stranded RNA to mimic viral infection for cancer immunotherapy.
Journal article
Martinez-Riaño A. et al, (2024), Clinical cancer research : an official journal of the American Association for Cancer Research
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.
Journal article
Hobor S. et al, (2024), Nature communications, 15
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040.
Journal article
Melero I. et al, (2024), Annals of oncology : official journal of the European Society for Medical Oncology, 35, 537 - 548